CMS Medicare Formulary Standards Will Have More “Granularity” Than USP
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Medicare & Medicaid Services expects its reviews of Medicare Rx drug plan formularies to include evaluation of drug choices at the “sub-class” level. The standards will also aim to encourage plans to provide more than the minimum two drugs per formulary class.
You may also be interested in...
CMS Finalizing Plans For Medicare Rx Regions, Formulary Standards
Agency is expected to publish documents defining regional maps for Medicare Rx and standards for review of Medicare formularies in the next two weeks – and potentially by Dec. 3.
CMS Finalizing Plans For Medicare Rx Regions, Formulary Standards
Agency is expected to publish documents defining regional maps for Medicare Rx and standards for review of Medicare formularies in the next two weeks – and potentially by Dec. 3.
Medicare Rx “Dual Eligibles” Will Influence Formulary Design, Insurer Says
Most dual eligibles joining Medicare Rx plans will be accustomed to closed formularies, which should be taken into consideration when designing benefits, exec from UnitedHealth Group’s Ovations business says. Formularies with tiered cost sharing would not be effective for low-income beneficiaries, he says.